Markedsdata leveret af TwelveData og Morningstar
co.don AG is a Germany-based biotechnology and regenerative medicine company focused on developing, producing, and providing autologous cell therapies for tissue repair. Its core activities center on cultivating a patient’s own cells into biological products designed for minimally invasive treatment of cartilage and other musculoskeletal conditions. The company’s portfolio includes Spherox, a three-dimensional chondrocyte product used in matrix-associated autologous chondrocyte transplantation for articular cartilage defects in the knee. Its broader product applications include cartilage repair, intervertebral disc regeneration, bone healing, and dental procedures. co.don AG serves medical specialists and clinical institutions, including orthopedic surgeons, accident surgeons, neurosurgeons, and specialized practices. Through its combination of cell cultivation, biotechnology, and clinical applications, the company operates at the intersection of healthcare services, advanced therapeutics, and regenerative medicine, addressing conditions where conventional repair techniques may be limited.